Aspire Biopharma Holdings ASBP
NASDAQ ASBP
$8.65 -0.07 (-0.80%)
As of: Oct 21, 2026 · 12:31 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Notes Payables (2021 - 2025)

Updated

Aspire Biopharma Holdings (ASBP) recorded Notes Payables of $885,564 in Q4 2025, down 30.1% from $1.27 million a year earlier and unchanged from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Notes Payables (2021 - 2025) Analysis & Trends

Starting with Q4 2021, Aspire Biopharma Holdings' Notes Payables history includes 6 quarters.

  • Annual Notes Payables has a four-year compound annual growth rate of 38.8% (FY2021 to FY2025).
  • Across earlier years, Notes Payables came in at $1.27 million in FY2024 and $238,596 in FY2021.
  • Quarterly Notes Payables has ranged from $238,596 in Q4 2021 to $1.33 million in Q2 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $885,564 (Q3 2025), $1.33 million (Q2 2025) and $1.21 million (Q1 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 885,564.00
Sep 30, 2025 885,564.00
Jun 30, 2025 1.33 Mn
Mar 31, 2025 1.21 Mn
Dec 31, 2024 1.27 Mn
Dec 31, 2021 238,596.00
API Access

Aspire Biopharma Holdings, Inc. Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ASBP&period=max&api_key=YOUR_API_KEY